HP-B-CD: AMD therapy with cholesterol-lowering capabilities
Investigators set out to determine if treatment crosses blood-retina barrier.
Related Articles
The evolving role of vitreosurgical simulators in surgical training
Need to eliminate errors results in optimization of training of novice surgeons.
Study evaluates the potential correlation of ultra-processed food consumption and increased glaucoma incidence
UPFs include fast food, energy drinks and soda, sweets such as chocolates and candies and much more.
The role of multimodal imaging in ocular trauma
Closed globe ocular injury often leads to macular pathology
What’s Your WhEYE? A conversation with Paul Badawi, CEO of Sight Sciences
Paul Badawi, co-founder and CEO of Sight Sciences, sits down with host Neda Shamie, MD, to discuss his journey into the field of eye care,…
Ophthalmologists embrace potential of clinically tested nutraceuticals for dry eye disease
Look beyond isolated treatment of the eye to address systemic factors.
Efficacy, safety of switching to latanoprostene bunod 0.024% in patients with OAG and OHT
The switch may produce an additional 25% IOP reduction in mild to moderate forms of disease
Treatment challenges in patients with nAMD
David Eichenbaum, MD, discusses his experiences with aflibercept, faricimab.
The evolving role of vitreosurgical simulators in surgical training
Need to eliminate errors results in optimization of training of novice surgeons.
Study evaluates the potential correlation of ultra-processed food consumption and increased glaucoma incidence
UPFs include fast food, energy drinks and soda, sweets such as chocolates and candies and much more.
The role of multimodal imaging in ocular trauma
Closed globe ocular injury often leads to macular pathology